Concepedia

Publication | Open Access

A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation

DOIFull Paper Access

182

Citations

29

References

2007

Year

Jing Xu, Zhongyang Shen, Xinguo Chen, Qing Zhang, Huijie Bian, Ping Zhu, Huiyun Xu, Fei Song, Xiang-Min Yang, Mi Li,
Hepatology

Abstract

Licartin is a promising drug for preventing post-OLT tumor recurrence in advanced HCC patients excluded by the currently strict criteria for OLT. HAb18G/CD147 can be a good drug target.

References

YearCitations

Page 1